Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids
More topics under "C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids" (173,078)
C07H 1 - Processes for the preparation of sugar derivatives (12,374)
C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
C07H 13 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids (4,753)
C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
C07H 3 - Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (5,762)
C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
C07H 99 - Subject matter not provided for in other groups of this subclass (52)
Patents for C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids (1,168)
01/2015
01/28/2015CN104311658A 新的受体核酸及多肽 The new receptor nucleic acids and peptides
01/13/2015US8933044 RNA interference mediating small RNA molecules
12/2014
12/30/2014US8921331 Methods for slowing familial ALS disease progression
11/2014
11/25/2014US8895721 RNA interference mediating small RNA molecules
11/25/2014US8895718 RNA interference mediating small RNA molecules
10/2014
10/07/2014US8853384 RNA interference mediating small RNA molecules
08/2014
08/28/2014US20140243517 Methods of producing c-aryl glucoside sglt2 inhibitors
08/19/2014US8808984 Method for synthesising templated molecules
08/05/2014US8796016 RNA interference mediating small RNA molecules
07/2014
07/29/2014US8790922 RNA sequence-specific mediators of RNA interference
07/15/2014US8778902 RNA interference mediating small RNA molecules
07/03/2014US20140187485 Novel receptor nucleic acids and polypeptides
07/01/2014US8765930 RNA interference mediating small RNA molecules
06/2014
06/03/2014US8742092 RNA sequence-specific mediators of RNA interference
05/2014
05/15/2014US20140135487 Immunostimulatory g, u-containing oligoribonucleotides
02/2014
02/25/2014US8658607 Immunostimulatory G, U-containing oligoribonucleotides
02/18/2014CA2429814C Rna interference mediating small rna molecules
01/2014
01/21/2014US8632997 RNA sequence-specific mediators of RNA interference
12/2013
12/17/2013US8609135 Anthracycline derivatives
11/2013
11/28/2013US20130315863 Methods and compositions for treating flaviviridae infections
11/21/2013US20130310336 Methods and compositions for treating flaviviruses and pestiviruses
11/19/2013CA2404890C Rna sequence-specific mediators of rna interference
10/2013
10/08/2013US8552171 RNA sequence-specific mediators of RNA interference
09/2013
09/04/2013CN1622995B Receptor nucleic acids and polypeptides
09/03/2013US8524672 Method for inhibiting BAFF-R activity
08/2013
08/01/2013US20130198875 Rna sequence-specific mediators of rna interference
07/2013
07/30/2013CA2605671C Magnetic particles with a glass surface and their use
06/2013
06/05/2013CN101654672B RNA interference mediating small RNA molecules
05/2013
05/22/2013CN1974781B Enzyme reaction method for nucleic acid and composition for separating nucleic acid
05/21/2013US8445237 RNA interference mediating small RNA molecules
05/16/2013US20130125259 Rna interference mediating small rna molecules
04/2013
04/24/2013CN101643789B RNA interference mediating small RNA molecules
04/16/2013US8420391 RNA sequence-specific mediators of RNA interference
03/2013
03/12/2013US8394949 Multisignal labeling reagents, and processes and uses therefor
03/12/2013US8394628 RNA sequence-specific mediators of RNA interference
03/05/2013US8389702 Multi-oligomeric or multi-polymeric compositions comprising labeled moieties and binding partners
03/05/2013US8389701 Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners
02/2013
02/21/2013US20130045475 2-Nitrobenzyl-Modified Ribonucleotides
02/12/2013US8372968 RNA interference mediating small RNA molecules
01/2013
01/29/2013US8362231 RNA interference mediating small RNA molecules
01/01/2013US8343937 Methods and compositions for treating flaviviruses and pestiviruses
12/2012
12/25/2012US8338387 Small molecule stimulators of neuronal growth
12/11/2012US8329463 RNA interference mediating small RNA molecules
10/2012
10/30/2012US8299226 2-nitrobenzyl-modified ribonucleotides
10/10/2012CN101052414B Immunogenic HBc chimer particles having enhanced stability
09/2012
09/04/2012US8258105 Antisense oligonucleotides optimized for kidney targeting
08/2012
08/23/2012US20120214865 Methods for slowing familial als disease progression
08/14/2012CA2509687C Process for the production of 2'-branched nucleosides
08/02/2012US20120196921 Modulation of sglt-2 expression
07/2012
07/04/2012CN101076537B Oligonucleotides labeled with a plurality of fluorophores
05/2012
05/17/2012US20120122111 Rna sequence-specific mediators of rna interference
04/2012
04/25/2012EP2444482A1 Modulation of SGLT2 expression
04/10/2012US8153609 Purine nucleotide derivatives
04/10/2012US8153141 Immunostimulatory G, U-containing oligoribonucleotides
03/2012
03/22/2012US20120070437 Method of identifying compounds that bind baff-r
02/2012
02/16/2012US20120040345 2-Nitrobenzyl-Modified Ribonucleotides
02/02/2012US20120029061 Rna sequence-specific mediators of rna interference
01/2012
01/19/2012US20120015042 Rna sequence-specific mediators of rna interference
12/2011
12/28/2011EP2399588A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
12/27/2011US8084436 Modulation of SGLT2 expression
12/15/2011US20110306651 Rna interference mediating small rna molecules
12/15/2011US20110305721 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/2011
11/24/2011US20110289611 Rna sequence-specific mediators of rna interference
11/17/2011US20110281931 Rna sequence-specific mediators of rna interference
10/2011
10/18/2011US8041421 Transdermal delivery system for polynucleotides
10/12/2011CN101006177B An improved method for synthesising templated molecules
10/06/2011US20110245318 Rna sequence-specific mediators of rna interference
10/06/2011US20110244568 Rna sequence-specific mediators of rna interference
10/06/2011US20110244446 Rna sequence-specific mediators of rna interference
10/05/2011EP1660682B1 ANTISENSE MODULATION OF p38 MITOGEN ACTIVATED PROTEIN KINASE EXPRESSION
09/2011
09/28/2011EP2368431A1 Immunostimulatory G,U-containing oligoribonucleotides
09/27/2011US8026072 Method of identifying compounds that bind BAFF-R
09/20/2011US8022194 2′-nitrobenzyl-modified ribonucleotides
09/20/2011CA2468552C 3-.beta.-d-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof
09/01/2011US20110213136 Antisense modulation of stearoyl-coa desaturase expression
08/2011
08/31/2011EP2361981A1 RNA sequence-specific mediators of RNA interference
08/24/2011EP2360253A1 RNA sequence-specific mediators of RNA interference
08/24/2011EP2360166A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
08/18/2011US20110201795 Methods of Producing C-Aryl Glucoside SGLT2 Inhibitors
08/03/2011EP2351852A1 RNA interference mediating small RNA molecules
08/02/2011US7989605 Compounds and methods for immunotherapy and diagnosis of tuberculosis
07/2011
07/27/2011EP2348134A1 RNA interference mediating small RNA molecules
07/27/2011EP2348133A1 RNA interference mediating small RNA molecules
07/20/2011EP2345742A1 RNA sequence-specific mediators of RNA interference
07/19/2011US7981868 Antisense oligonucleotide chemically modified with a phosphorothioate linkage, a 2'-O-methoxyethyl modified sugar, or 5-methylated cytosine; antiinflammatory agents that reduce mucus production in airways
06/2011
06/14/2011US7960358 Antisense modulation of stearoyl-CoA desaturase expression
05/2011
05/25/2011EP2325317A1 Receptor nucleic acids and polypeptides
05/12/2011US20110112283 Rna interference mediating small rna molecules
05/11/2011EP2319853A1 Process for the production of 2'-branched nucleosides
04/2011
04/26/2011US7932379 Methods of producing C-aryl glucoside SGLT2 inhibitors
04/12/2011US7923550 Reagent compounds and methods of making and using the same
04/06/2011EP2305808A1 Templated molecules and methods for using such molecules
03/2011
03/29/2011US7915234 Pharmaceutically active uridine esters
03/24/2011US20110070162 Rna interference mediating small rna molecules
03/17/2011US20110065773 Rna interference mediating small rna molecules
03/17/2011US20110065109 Rna interference mediating small rna molecules
03/03/2011US20110054159 Rna interference mediating small rna molecules
03/03/2011US20110053154 2'-nitrobenzyl-modified ribonucleotides
02/2011
02/23/2011EP1740599B1 Anthracycline derivatives
02/03/2011US20110028692 Multisignaling oligomeric or polymeric compositions comprising labeled moieties and binding partners
1 2 3 4 5 6 7 8 9 10 11 ... 12